Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von StackerofWheat 

Bellicum Pharmaceuticals Inc. diskutieren

Bellicum Pharmaceuticals Inc.

WKN: A2PZPL / Symbol: BLCM / Name: Bellicum Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

0,064 €
-9,29 %

0 13
0
13

Buy Bellicum Pharmaceuticals Inc.

StackerofWheat 
0
Melden Teilen
15.10.19 Buy 1,27 %
Einschätzung Buy
Rendite (%) -74,51 %
Kursziel 6,31
Veränderung
Endet am 30.10.19

Buy closed

melinda 
0
Melden Teilen
30.10.19
Einschätzung Buy
Rendite (%) 1,27 %
Kursziel
Veränderung
Endet am 15.12.19

Buy beendet

StackerofWheat 
0
Melden Teilen
15.12.19

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
22.04.23 Sell -22,38 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
30.04.23 Sell -30,34 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
25.06.23 Sell -46,03 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
12.08.23 Sell -60,24 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
20.08.23 Sell -54,21 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
07.10.23 Sell -37,79 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
15.10.23 Sell -18,09 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
24.11.23 Sell -61,52 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
02.12.23 Sell -47,08 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
10.12.23 Sell -58,22 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
26.12.23 Sell -51,89 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
27.01.24 Sell -19,11 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
04.02.24 Sell -9,93 %

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
23.03.24 Sell -

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLCM provided by MarketBeat

StockNews.com 
0
Melden Teilen
31.03.24 Sell -
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

Morgan_Stanley in SI-BONE Inc diskutieren
SI-BONE, Inc. (NASDAQ: SIBN) had its price target lowered...
19:30
Royal_Bank_of_Canada in Varonis Systems Inc. diskutieren
Varonis Systems, Inc. (NASDAQ: VRNS) had its price target...
17:15
DA_Davidson in WillScot Mobile Mini Holdings Corp. diskutieren
WillScot Mobile Mini Holdings Corp. (NASDAQ: WSC) had its...
17:01
HC_Wainwright in Eledon Pharmaceuticals Inc. diskutieren
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its price...
17:01
Stephens in Addus Homecare Corp. diskutieren
Addus HomeCare Co. (NASDAQ: ADUS) had its "overweight" r...
17:01
StockNews_com in Gran Tierra Energy Inc. diskutieren
Gran Tierra Energy Inc. (NYSE: GTE) was upgraded by anal...
15:45
Chardan_Capital in EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its pri...
15:15
Benchmark_Co_ in Tetra Techs diskutieren
TETRA Technologies, Inc. (NYSE: TTI) had its "buy" ratin...
15:15
Mehr anzeigen